Clinical Trial Update: Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating quercetin's effect on glucose absorption in individuals with obesity and obesity-associated type 2 diabetes has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Quercetin (quercetin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Obesity, Diabetes | Phase 2 | Status: COMPLETED